4559:TYO
Zeria Pharmaceutical Co Ltd
1 914,00 JP¥
arrow_upward
+0,58%(+11,00) 1D
6 қаз., 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
1 903 JP¥
High
1 919 JP¥
Low
1 900 JP¥
Mkt. cap
95,93 млрд
Avg. vol.
169,91 м.
Volume
137,50 м.
Dividend
2,56%
Quarterly dividend
12 JP¥
Ex-dividend date
2026 ж. 29 қыр.
P/E ratio
10,25
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 млн
No. of employees
2 мың
Open
1 903 JP¥
High
1 919 JP¥
Low
1 900 JP¥
Mkt. cap
95,93 млрд
Avg. vol.
169,91 м.
Volume
137,50 м.
Dividend
2,56%
Quarterly dividend
12 JP¥
Ex-dividend date
2026 ж. 29 қыр.
P/E ratio
10,25
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 млн
No. of employees
2 мың
News stories
From web sources and news partners
Benzinga
·
1 сағат бұрын
BOXABL (NASDAQ: BXBL) Adds Former EY Audit Partner Timothy Goldsmith to Board as Audit Committee Chair
The Washington Post
·
33 минут бұрын
Stocks hit new record high even as consumers feel dreary
MarketForces Africa
·
5 минут бұрын
XRP Establishes Price Floor Ahead Of Evernorth Nasdaq Listing
The Motley Fool
·
46 минут бұрын
Stock Market Midday, Oct. 6: S&P 500 Sets New High, Nuclear Stocks Surge
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1,75 мың
Founded1955 ж. 22 жел.
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp